Results 231 to 240 of about 267,153 (398)
The COVID-19 Serology Studies Workshop: Recommendations and Challenges
Andrea M. Lerner +6 more
semanticscholar +1 more source
We reported a patient who presented with transient focal neurological symptoms. The contrast‐enhanced brain magnetic resonance imaging (MRI) of this patient demonstrated significant enhancement of the dura mater, pia mater, and spinal meninges. Based on the positive result of single photon emission computed tomography (SPECT), we promptly determined ...
Fen Li +6 more
wiley +1 more source
Helminth or Host? Rethinking the Etiology of Transverse Myelitis. [PDF]
Messina C.
europepmc +1 more source
Immune adherence hemagglutination: alternative to complement-fixation serology [PDF]
E T Lennette, David A. Lennette
openalex +1 more source
PIVKA‐II comprises two heterogeneous molecular forms with different levels regarding hydrophobicity, and PIVKA‐II in serum and plasma exists as distinct molecular forms with varying levels. ABSTRACT Background Protein induced by the absence of vitamin K or antagonist‐II (PIVKA‐II) is an important serological biomarker for the diagnosis of ...
Yoshiyuki Kitamura, Katsumi Aoyagi
wiley +1 more source
The Proportion of <i>Treponema pallidum</i> Polymerase Chain Reaction-Positive Primary Syphilis Infections That Are Seronegative for Syphilis: A Systematic Review and Meta-analysis. [PDF]
Hughes Y +11 more
europepmc +1 more source
The serology of experimental Salmonella dublin infections of cattle [PDF]
G.A. Hall +3 more
openalex +1 more source
A Proposal for a Serology-Based Approach to Membranous Nephropathy.
A. D. De Vriese +4 more
semanticscholar +1 more source
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai +8 more
wiley +1 more source

